SSP

SSP for Combisal® 125mcg/25mcg inhalers extended

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Combisal® 125mcg/25mcg pressurised metered dose inhaler (pMDI) (SSP034).

SSP034 for Combisal® 125mcg/25mcg pMDI was previously expected to expire on 19th August 2022 but the end date has been further extended to Wednesday 28th September 2022.

This expiry date may be brought forward or extended, and the content may be amended throughout this period. Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product.

For Further Details